CDMO Profile

Miltenyi Bioindustries

Miltenyi Bioindustries Contract Manufacturing & Development (CDMO) Profile

Miltenyi Bioindustry supports all efforts, from pre-clinical to commercial scale, as a full-service provider for the development and manufacturing of lentiviral vectors (LVVs) and cell and gene therapy (CGT) products. As a globally active CDMO (Contract Development and Manufacturing Organization) with over 30 years of extensive know-how, we are helping to shape this rapidly growing arena. We leverage the latest technology platforms to make your vision of commercial-scale manufacturing a reality. We are a division of Miltenyi Biotec, a pioneering innovator and provider of cell processing and analytical platforms, LVVs, and ancillary materials in this field.

CDMO Services:
Biologics; Cell & Gene Therapy Drug Substance Manufacturing (API); Drug Product Formulation (FDF); Clinical Trials materials and logistics; Regulatory Services

Year Founded: 1989

Head Office: Bergisch Gladbach, Germany

Number of Facilities: 3-5

Facility locations: Europe; North America; China

Website: Visit the Miltenyi Bioindustries website

Linkedin: Connect on Linkedin

Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing.  Register here

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

INFOGRAPHIC

Download the latest infographic summarising key players in Small Molecule, Biologics and Cell & Gene Therapies.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.